245 related articles for article (PubMed ID: 19304434)
21. Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection.
Kumar M; Sarin SK
Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):465-95. PubMed ID: 19072396
[TBL] [Abstract][Full Text] [Related]
22. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
[TBL] [Abstract][Full Text] [Related]
23. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
Sumethkul V; Ingsathit A; Jirasiritham S
Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516
[TBL] [Abstract][Full Text] [Related]
24. Surveillance and treatment protocols to detect and treat hepatitis B virus reactivation in hepatitis B surface antigen-negative/antibody to hepatitis B core antigen-positive patients receiving chemotherapy for onco-hematologic malignancies.
Marignani M; Marzano A
J Clin Oncol; 2011 Mar; 29(8):e210; author reply e211. PubMed ID: 21220585
[No Abstract] [Full Text] [Related]
25. [Hepatitis B virus reactivation in patients with HBs antibodies after allogeneic hematopoietic stem cell transplantation].
Fujimaki K; Nakaseko C; Oshima K; Sakai M; Chou R; Kanda Y; Nishimura M; Kanamori H; Sakamaki H
Rinsho Ketsueki; 2007 May; 48(5):386-90. PubMed ID: 17571583
[TBL] [Abstract][Full Text] [Related]
26. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].
Woo SY; Cho SH; Lee SM; Koh MB; Noh CH; Kim CW; Choi JY; Yang JM; Han JY; Lee YS
Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765
[TBL] [Abstract][Full Text] [Related]
27. HBs seroconversion in a patient with acute hepatitis B treated with entecavir during immunosuppression against severe bronchiolitis obliterans in the course of chronic graft versus host disease.
Christopeit M; Weber T; Abendroth J; Dollinger M; Lübbert C; Oehme A; Kekulé AS; Behre G
J Clin Virol; 2010 Jul; 48(3):218-9. PubMed ID: 20403727
[TBL] [Abstract][Full Text] [Related]
28. Lamivudine treatment in a patient with hepatitis B virus reactivation after allogenic peripheral bone marrow transplantation.
Imamura T; Yokosuka O; Chiba T; Kanda T; Kojima H; Fukai K; Imazeki F; Nishimura M; Saito Y; Saisho H
Leuk Lymphoma; 2005 Jun; 46(6):915-7. PubMed ID: 16019538
[TBL] [Abstract][Full Text] [Related]
29. Horse antilymphocytic globulin in hepatitis B exacerbation after bone marrow transplantation adoptive immunity transfer.
Favre C; Menconi MC; Nardi M; Casazza G; Oliveri F; Macchia P; Bonino F; Brunetto MR
Bone Marrow Transplant; 2004 May; 33(10):1057-9. PubMed ID: 15048140
[TBL] [Abstract][Full Text] [Related]
30. [Efficacity of treatment with lamivudine in two patients with severe reactivation of hepatitis B after withdrawal of chemotherapy].
Seksik P; Nahon S; Lesgourgues B; Cadranel JF; Mariaud De Serre N; Lenoble M; Lahmeck P; Charoud A; Delas N
Gastroenterol Clin Biol; 2000; 24(6-7):671-4. PubMed ID: 10962392
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B reactivation following allogeneic bone marrow transplantation: case report and review of the literature.
Martin BA; Rowe JM; Kouides PA; DiPersio JF
Bone Marrow Transplant; 1995 Jan; 15(1):145-8. PubMed ID: 7742749
[TBL] [Abstract][Full Text] [Related]
32. Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B.
Borgniet O; Parvaz P; Bouix C; Chevallier P; Trépo C; André P; Zoulim F
J Med Virol; 2009 Aug; 81(8):1336-42. PubMed ID: 19551826
[TBL] [Abstract][Full Text] [Related]
33. Lamivudine therapy for hepatitis B infection in post-renal transplant patients: results after 36 months follow-up.
de Silva HJ; Herath CA; Sheriff MH
Liver Int; 2005 Oct; 25(5):1074-5. PubMed ID: 16162169
[No Abstract] [Full Text] [Related]
34. [Loss or seroconversion of HBsAg in patients with chronic hepatitis B after treatment with lamivudine: 2 cases report].
Zhao KK; Miao QL; Bi LN
Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):871. PubMed ID: 21138644
[No Abstract] [Full Text] [Related]
35. [Lamivudine treatment of a HBs antigen positive man with reactive arthritis].
Borup C; Siboni A
Ugeskr Laeger; 2008 Nov; 170(48):3940-1. PubMed ID: 19087731
[TBL] [Abstract][Full Text] [Related]
36. [Lamivudine therapy in patients with severe acute hepatitis B].
Roznovský L; Orságová I; Kloudová A; Mrázek J
Klin Mikrobiol Infekc Lek; 2007 Apr; 13(2):59-65. PubMed ID: 17599294
[TBL] [Abstract][Full Text] [Related]
37. American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.
Reddy KR; Beavers KL; Hammond SP; Lim JK; Falck-Ytter YT;
Gastroenterology; 2015 Jan; 148(1):215-9; quiz e16-7. PubMed ID: 25447850
[No Abstract] [Full Text] [Related]
38. Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of Lamivudine prophylaxis.
Coiffier B
Cancer Invest; 2006; 24(5):548-52. PubMed ID: 16939967
[TBL] [Abstract][Full Text] [Related]
39. Current topics in hepatitis B.
Zuckerman JN; Zuckerman AJ
J Infect; 2000 Sep; 41(2):130-6. PubMed ID: 11023756
[TBL] [Abstract][Full Text] [Related]
40. Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: prophylactic or preemptive?
Dai MS; Chao TY
Breast Cancer Res Treat; 2005 Jul; 92(1):95-6. PubMed ID: 15980997
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
